2019
DOI: 10.1016/j.canlet.2019.02.047
|View full text |Cite
|
Sign up to set email alerts
|

Lung cancer survival among never smokers

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

3
26
0
2

Year Published

2019
2019
2023
2023

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 46 publications
(31 citation statements)
references
References 30 publications
3
26
0
2
Order By: Relevance
“…Lung cancer is the most common cancer (11.6 % of total cancers) and the leading cause of death from cancers worldwide (18.4 % of total cancer deaths) [1], with adenocarcinoma being the most common histological type of lung cancer [2,3]. A new classification of lung adenocarcinoma was established in 2011, dividing lung adenocarcinoma into atypical adenomatous hyperplasia (AAH), adenocarcinoma in situ (AIS), minimally invasive adenocarcinoma (MIA) and invasive adenocarcinoma (IAC) [4], consistent with the classification of lung adenocarcinoma published by WHO in 2015 [5].…”
Section: Introductionmentioning
confidence: 99%
“…Lung cancer is the most common cancer (11.6 % of total cancers) and the leading cause of death from cancers worldwide (18.4 % of total cancer deaths) [1], with adenocarcinoma being the most common histological type of lung cancer [2,3]. A new classification of lung adenocarcinoma was established in 2011, dividing lung adenocarcinoma into atypical adenomatous hyperplasia (AAH), adenocarcinoma in situ (AIS), minimally invasive adenocarcinoma (MIA) and invasive adenocarcinoma (IAC) [4], consistent with the classification of lung adenocarcinoma published by WHO in 2015 [5].…”
Section: Introductionmentioning
confidence: 99%
“…The literature confirms that lung cancer among non-smokers exhibits distinctive clinical characteristics, is more common in women and is diagnosed at later stages and that adenocarcinoma is the predominant histological type [ 31 , 32 , 33 ]. Meanwhile, tobacco smoking is associated with squamous and small cell types of lung cancer, as well as with an earlier age at the time of diagnosis [ 34 ], which leads to a generally poorer prognosis for patients in this group.…”
Section: Discussionmentioning
confidence: 78%
“…These techniques are usually not practical, and are expensive, for most early NSCLC detection ( 4 ). According to Hu et al ( 5 ) and Chen et al ( 6 ), serum miRNA, as a potential biomarker for the diagnosis and prediction of prognosis of lung cancer, and may be useful for the detection of NSCLC and provides high sensitivity and specificity ( 7 ).…”
Section: Introductionmentioning
confidence: 99%